These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 1386063

  • 1. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML, Kang LY, Rankin JG, Coates RA, Corey PN, Hu ZH, Zhou TK, Yuan GJ, Yao FL.
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM, del Canho R, Voogd M, Heijtink RA, Schalm SW.
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [Abstract] [Full Text] [Related]

  • 4. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers.
    Lo KJ, Tsai YT, Lee SD, Wu TC, Wang JY, Chen GH, Yeh CL, Chiang BN, Yeh SH, Goudeau A.
    J Infect Dis; 1985 Oct; 152(4):817-22. PubMed ID: 2931490
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.
    Vaccine; 2014 Oct 21; 32(46):6091-7. PubMed ID: 25240752
    [Abstract] [Full Text] [Related]

  • 8. Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage.
    Poovorawan Y, Sanpavat S, Pongpunlert W, Chumdermpadetsuk S, Sentrakul P, Chitinand S, Sakulramrung R, Tannirundorn Y.
    Vaccine; 1990 Mar 21; 8 Suppl():S56-9; discussion S60-2. PubMed ID: 2139286
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1986 Jun 21; 4(1):33-6. PubMed ID: 3730058
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B immunization in high risk neonates born from HBsAg and HBeAg positive mothers: comparison of standard and low dose regimens.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1988 Dec 21; 6(2):107-10. PubMed ID: 2975491
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1989 Jun 21; 7(1):37-40. PubMed ID: 2526633
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Lu Y, Liang XF, Wang FZ, Yan L, Li RC, Li YP, Zhu FC, Zhai XJ, Li J, Zhuang H.
    Vaccine; 2017 Jan 03; 35(1):40-45. PubMed ID: 27894717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of recombinant hepatitis B vaccine in infants born to HBsAg-positive mothers.
    Yeoh EK, Chang WK, Ip P, Chan KH, Chan E, Fung C.
    J Infect; 1986 Jul 03; 13 Suppl A():15-8. PubMed ID: 2943811
    [Abstract] [Full Text] [Related]

  • 16. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine.
    Halliday ML, Rankin JG, Bristow NJ, Coates RA, Corey PN, Strickler AC.
    Arch Intern Med; 1990 Jun 03; 150(6):1195-200. PubMed ID: 2141247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand.
    Lolekha S, Warachit B, Hirunyachote A, Bowonkiratikachorn P, West DJ, Poerschke G.
    Vaccine; 2002 Nov 01; 20(31-32):3739-43. PubMed ID: 12399203
    [Abstract] [Full Text] [Related]

  • 19. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K, Gunn T, Woodfield DG.
    N Z Med J; 1987 Jul 08; 100(827):412-4. PubMed ID: 2967932
    [Abstract] [Full Text] [Related]

  • 20. Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report.
    Zanetti AR, Dentico P, Del Vecchio Blanco C, Sagnelli E, Villa E, Ferroni P, Bergamini F.
    J Med Virol; 1986 Apr 08; 18(4):327-34. PubMed ID: 2940333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.